Analyst Ratings for Hemab Therapeutics Holdings (COAG)
COAG Rating Summary
COAG Price Target Summary
- Highest: $70.00 (JPMorgan)
- Lowest: $36.00 (Goldman Sachs)
- Average: $53.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$53.67 (+78.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | JPMorgan | Joyce Zhou | New Coverage | Overweight (N/A) |
70.00 (N/A) |
29.80 (30.07) |
0.91% | Details |
| 10/12/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
56.00 (N/A) |
31.62 (30.07) |
-4.9% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
